JP2011522842A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011522842A5 JP2011522842A5 JP2011512782A JP2011512782A JP2011522842A5 JP 2011522842 A5 JP2011522842 A5 JP 2011522842A5 JP 2011512782 A JP2011512782 A JP 2011512782A JP 2011512782 A JP2011512782 A JP 2011512782A JP 2011522842 A5 JP2011522842 A5 JP 2011522842A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- composition according
- tyrosine
- peptide
- cysteine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0095108A AT506819B1 (de) | 2008-06-12 | 2008-06-12 | Vakzin zur behandlung von alzheimer-krankheit |
| AT0095208A AT506820B1 (de) | 2008-06-12 | 2008-06-12 | Vakzine gegen alzheimer-krankheit |
| ATA951/2008 | 2008-06-12 | ||
| ATA952/2008 | 2008-06-12 | ||
| PCT/AT2009/000237 WO2009149487A2 (en) | 2008-06-12 | 2009-06-12 | Compounds for treating symptoms associated with parkinson's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011522842A JP2011522842A (ja) | 2011-08-04 |
| JP2011522842A5 true JP2011522842A5 (https=) | 2012-07-19 |
Family
ID=41417160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011512782A Pending JP2011522842A (ja) | 2008-06-12 | 2009-06-12 | パーキンソン病に関連する症状の治療のための化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20110092436A1 (https=) |
| EP (1) | EP2310032A2 (https=) |
| JP (1) | JP2011522842A (https=) |
| KR (1) | KR20110036809A (https=) |
| CN (1) | CN102123726A (https=) |
| AU (1) | AU2009257170B2 (https=) |
| BR (1) | BRPI0915134A2 (https=) |
| CA (1) | CA2723995A1 (https=) |
| IL (1) | IL209896A0 (https=) |
| MX (1) | MX2010013647A (https=) |
| RU (1) | RU2011100127A (https=) |
| WO (1) | WO2009149487A2 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3042917T (pt) | 2010-08-12 | 2018-05-02 | Lilly Co Eli | Anticorpos do péptido beta amilóide anti-n3pglu e seus usos |
| SI2579042T1 (sl) | 2011-10-04 | 2014-09-30 | Affiris Ag | Postopek za detektiranje Ass-specifičnih protiteles v biološkem vzorcu |
| EP2659908A1 (en) | 2012-05-01 | 2013-11-06 | Affiris AG | Compositions |
| WO2015165961A1 (en) | 2014-04-29 | 2015-11-05 | Affiris Ag | Treatment and prevention of alzheimer's disease (ad) |
| WO2015185602A1 (en) * | 2014-06-04 | 2015-12-10 | Affiris Ag | Treatment and prevention of parkinson's disease (pd) |
| WO2016131420A1 (zh) * | 2015-02-17 | 2016-08-25 | 上海交通大学医学院附属上海儿童医学中心 | 急性淋巴细胞白血病耐药复发相关突变基因及其应用 |
| US10759837B2 (en) | 2015-11-09 | 2020-09-01 | The University Of British Columbia | Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide |
| US10772969B2 (en) | 2015-11-09 | 2020-09-15 | The University Of British Columbia | N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto |
| CA3004494A1 (en) | 2015-11-09 | 2017-05-18 | The University Of British Columiba | Epitopes in amyloid beta mid-region and conformationally-selective antibodies thereto |
| JOP20170004B1 (ar) | 2016-01-15 | 2022-09-15 | Lilly Co Eli | الأجسام المضادة لببتيد بيتا النشوي مضاد N3pGlu واستخداماته |
| TWI798751B (zh) | 2016-07-01 | 2023-04-11 | 美商美國禮來大藥廠 | 抗－N3pGlu類澱粉β肽抗體及其用途 |
| CN109476729A (zh) | 2016-07-18 | 2019-03-15 | 英属哥伦比亚大学 | 淀粉样蛋白β的抗体 |
| US20180125920A1 (en) | 2016-11-09 | 2018-05-10 | The University Of British Columbia | Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions |
| CN106632607A (zh) * | 2016-12-29 | 2017-05-10 | 华东理工大学 | 靶向survivin纳米抗体及其制备方法和应用 |
| TWI705975B (zh) | 2017-04-20 | 2020-10-01 | 美商美國禮來大藥廠 | 抗－N3pGlu類澱粉β肽抗體及其用途 |
| ES2984844T3 (es) | 2017-07-18 | 2024-10-31 | Univ British Columbia | Anticuerpos contra beta amiloide |
| US12286469B2 (en) | 2017-07-18 | 2025-04-29 | The University Of British Columbia | Humanized antibodies binding to amyloid-beta (A-beta) |
| CN108191966B (zh) * | 2018-01-11 | 2020-10-27 | 桂林医学院 | 一种含导肽可穿越血脑屏障螯合脑内铁降自由基的多肽 |
| CN110156887B (zh) * | 2018-02-12 | 2023-01-13 | 中国人民解放军军事科学院军事医学研究院 | 人vasn蛋白抗原表位、抗原模拟表位及其用途 |
| CN108676071B (zh) * | 2018-05-24 | 2021-05-14 | 华南理工大学 | 一种抗Aβ蛋白聚集的七肽及其应用与编码该合成多肽的基因 |
| CN108676072B (zh) * | 2018-05-24 | 2021-05-14 | 华南理工大学 | 一种具有抗Aβ42蛋白聚集功能的多肽及其应用与编码该多肽的基因 |
| CN111040020B (zh) * | 2018-12-28 | 2022-04-12 | 中国人民解放军军事科学院军事医学研究院 | 一种烯烃硫醚类订书肽及其制备方法与应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179892B2 (en) * | 2000-12-06 | 2007-02-20 | Neuralab Limited | Humanized antibodies that recognize beta amyloid peptide |
| CZ20022748A3 (cs) * | 2000-02-21 | 2004-03-17 | Pharmexa A/S | Nová metoda regulace obsahu amyloidu |
| US20040067535A1 (en) * | 2002-10-03 | 2004-04-08 | Life Sciences Development Corp. | Alzheimer's disease linked genes |
| TW200509968A (en) * | 2002-11-01 | 2005-03-16 | Elan Pharm Inc | Prevention and treatment of synucleinopathic disease |
| US20040265849A1 (en) * | 2002-11-22 | 2004-12-30 | Applera Corporation | Genetic polymorphisms associated with Alzheimer's disease, methods of detection and uses thereof |
| AT413945B (de) * | 2003-01-14 | 2006-07-15 | Mattner Frank Dr | Impfstoff für die alzheimer-krankheit |
| US20050176030A1 (en) * | 2003-10-28 | 2005-08-11 | Li Gan | Regulated nucleic acids in pathogenesis of Alzheimer's Disease |
| JP2005330231A (ja) * | 2004-05-20 | 2005-12-02 | Otsuka Pharmaceut Co Ltd | 医薬組成物 |
| AT413946B (de) * | 2004-07-13 | 2006-07-15 | Mattner Frank Dr | Impfstoff gegen die alzheimer-krankheit |
| GT200600031A (es) * | 2005-01-28 | 2006-08-29 | Formulacion anticuerpo anti a beta | |
| JP2011511841A (ja) * | 2008-02-12 | 2011-04-14 | ブリストル−マイヤーズ スクイブ カンパニー | Ｃ型肝炎ウイルス阻害剤 |
-
2009
- 2009-06-12 RU RU2011100127/15A patent/RU2011100127A/ru not_active Application Discontinuation
- 2009-06-12 US US12/997,702 patent/US20110092436A1/en not_active Abandoned
- 2009-06-12 JP JP2011512782A patent/JP2011522842A/ja active Pending
- 2009-06-12 KR KR1020117000819A patent/KR20110036809A/ko not_active Ceased
- 2009-06-12 WO PCT/AT2009/000237 patent/WO2009149487A2/en not_active Ceased
- 2009-06-12 EP EP20090761154 patent/EP2310032A2/en not_active Withdrawn
- 2009-06-12 AU AU2009257170A patent/AU2009257170B2/en not_active Expired - Fee Related
- 2009-06-12 CA CA2723995A patent/CA2723995A1/en not_active Abandoned
- 2009-06-12 BR BRPI0915134A patent/BRPI0915134A2/pt not_active IP Right Cessation
- 2009-06-12 MX MX2010013647A patent/MX2010013647A/es not_active Application Discontinuation
- 2009-06-12 CN CN2009801313674A patent/CN102123726A/zh active Pending
-
2010
- 2010-12-09 IL IL209896A patent/IL209896A0/en unknown
-
2013
- 2013-02-19 US US13/770,594 patent/US20130287807A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011522842A5 (https=) | ||
| RU2011100127A (ru) | Соединение, содержащее пептид, для лечения симптомов болезни паркинсона | |
| RU2011100125A (ru) | Соединения для лечения амилоидозов | |
| RU2011100126A (ru) | Применение мимотопов для лечения бетта-амилоидозов | |
| CN1241942C (zh) | 使用胰岛素的肽类似物治疗糖尿病的方法 | |
| AU2019250206A1 (en) | Novel immunogenic peptides | |
| JP2013518115A5 (https=) | ||
| US20140113874A1 (en) | Modified Compstatin With Improved Stability And Binding Properties | |
| CA2489227A1 (en) | Hla-a24-restricted cancer antigen peptides | |
| JP2006514104A5 (https=) | ||
| JP2016500682A5 (https=) | ||
| JP2003503312A5 (https=) | ||
| RU2007145052A (ru) | Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера | |
| RU2007125381A (ru) | Варианты il-7 со сниженной иммуногенностью | |
| TWI455721B (zh) | 癌疫苗組合物 | |
| TW201348252A (zh) | Ｇｉｐ－ｇｌｐ－１雙重促效劑化合物及方法 | |
| JP2009532385A5 (https=) | ||
| RU2013139651A (ru) | Новые соединения, влияющие на пищевое поведение | |
| HRP20160594T1 (hr) | Uporaba mimotopa od alfa-sinuklein epitopa za liječenje bolesti s lewyjevim tijelima | |
| JP2010536714A5 (https=) | ||
| RU2011153023A (ru) | Конъюгат амилоидного пептида и композиция на его основе для лечения или предупреждения заболевания, ассоциированного с отложением амилоидных белков | |
| ES2904471T3 (es) | Análogos de compstatina con solubilidad aumentada y propiedades farmacocinéticas mejoradas | |
| AR068020A1 (es) | Terapia combinada para el cancer de pancreas usando un peptido antigenico y un agente quimioterapeutico | |
| JP2009533355A5 (https=) | ||
| JP2010535818A5 (https=) |